Drug Information

Drug General Information
Drug ID
D0G6NY
Former ID
DNC006588
Drug Name
4-tert-butyl-N-(naphthalen-1-yl)thiazol-2-amine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528047]
Structure
Download
2D MOL

3D MOL
Formula
C17H18N2S
Canonical SMILES
CC(C)(C)C1=CSC(=N1)NC2=CC=CC3=CC=CC=C32
InChI
1S/C17H18N2S/c1-17(2,3)15-11-20-16(19-15)18-14-10-6-8-12-7-4-5-9-13(12)14/h4-11H,1-3H3,(H,18,19)
InChIKey
TXEFBOQHGSOELC-UHFFFAOYSA-N
PubChem Compound ID
9814340
Target and Pathway
Target(s) C-Cchemokine receptor type 4 Target Info Inhibitor [528047]
KEGG Pathway Cytokine-cytokine receptor interaction
Chemokine signaling pathway
Viral carcinogenesis
PANTHER Pathway Inflammation mediated by chemokine and cytokine signaling pathway
Reactome Chemokine receptors bind chemokines
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Peptide GPCRs
GPCR ligand binding
GPCR downstream signaling
References
Ref 528047Bioorg Med Chem Lett. 2006 May 15;16(10):2800-3. Epub 2006 Feb 23.Optimization of 2-aminothiazole derivatives as CCR4 antagonists.
Ref 528047Bioorg Med Chem Lett. 2006 May 15;16(10):2800-3. Epub 2006 Feb 23.Optimization of 2-aminothiazole derivatives as CCR4 antagonists.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.